Literature DB >> 17192899

Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder.

Dana E Rollison1, Wade J Sexton, Alejandro R Rodriguez, Loveleen C Kang, Richard Daniel, Keerti V Shah.   

Abstract

BK virus (BKV), a common human polyomavirus infection latent in the kidneys, can reactivate with immunosuppression to cause renal disease. Some have suggested that BKV may contribute to the development of bladder cancer, and BKV sequences have been reported from bladder tumors. To further examine the role of BKV in human bladder cancer, a series of bladder tumors was investigated for BKV genomic sequences. Fresh-frozen specimens from 76 transitional cell carcinoma tissues and 46 paired adjacent normal urothelial tissues archived at the H. Lee Moffitt Cancer Center were studied. All tissues were histopathologically reviewed. DNA extracted from the tissues was tested by quantitative real-time polymerase chain reaction (QPCR) assays to detect BKV DNA sequences in the VP1 coding region. Amplification of ERV-3 was conducted separately to quantify cell copy number. Conventional PCR targeting the BKV T-antigen (T-Ag) coding region and immunohistochemistry for BKV T-Ag were also conducted on all tissues that tested positive for BKV by QPCR. Seventy-three bladder tumors yielded >/=3,000 copies of ERV-3, 4 (5.5%) of which tested positive for BKV with average copy numbers of 7.9, 15.8, 0.4 and 0.3 per 1,000 cells. Paired normal tissue was available for 2 of these BKV-positive tumors, 1 of which was BKV-positive (14.6 copies/1,000 cells). No other normal tissues were BKV-positive by QPCR. The 6 BKV-positive tissues by QPCR were also positive by conventional PCR, but all stained negative for BKV T-Ag by immunohistochemistry. BKV is unlikely to be involved in the etiology of most bladder tumors. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17192899     DOI: 10.1002/ijc.22494

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Association of human herpes, papilloma and polyoma virus families with bladder cancer.

Authors:  Georgios I Panagiotakis; Danae Papadogianni; Maria N Chatziioannou; Ismini Lasithiotaki; Dimitrios Delakas; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2012-09-13

2.  Archetype and Rearranged Non-coding Control Regions in Urothelial Bladder Carcinoma of Immunocompetent Individuals.

Authors:  Elena Anzivino; Maria Antonella Zingaropoli; Marco Iannetta; Valeria Antonietta Pietropaolo; Alessandra Oliva; Francesco Iori; Antonio Ciardi; Donatella Maria Rodio; Francesca Antonini; Cesare Giovanni Fedele; Alessandra D'Abramo; Claudio Maria Mastroianni; Vincenzo Vullo; Maria Rosa Ciardi
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

3.  Survey for human polyomaviruses in cancer.

Authors:  Tuna Toptan; Samuel A Yousem; Jonhan Ho; Yuki Matsushima; Laura P Stabile; Maria-Teresa Fernández-Figueras; Rohit Bhargava; Akihide Ryo; Patrick S Moore; Yuan Chang
Journal:  JCI Insight       Date:  2016-02-25

Review 4.  BK virus and human cancer: innocent until proven guilty.

Authors:  Johanna R Abend; Mengxi Jiang; Michael J Imperiale
Journal:  Semin Cancer Biol       Date:  2009-02-21       Impact factor: 15.707

5.  Urinary human polyomavirus and papillomavirus infection and bladder cancer risk.

Authors:  J Polesel; T Gheit; R Talamini; N Shahzad; O Lenardon; B Sylla; C La Vecchia; D Serraino; M Tommasino; S Franceschi
Journal:  Br J Cancer       Date:  2011-11-24       Impact factor: 7.640

6.  High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection.

Authors:  Prue Hill; John Slavin; David Goodman
Journal:  NDT Plus       Date:  2009-02-26

Review 7.  Polyomaviruses and disease: is there more to know than viremia and viruria?

Authors:  Volker Nickeleit; Harsharan K Singh
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

Review 8.  BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches.

Authors:  Caroline Lamarche; Julie Orio; Suzon Collette; Lynne Senécal; Marie-Josée Hébert; Édith Renoult; Lee Anne Tibbles; Jean-Sébastien Delisle
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

9.  Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States.

Authors:  Gaurav Gupta; Sarat Kuppachi; Roberto S Kalil; Christopher B Buck; Charles F Lynch; Eric A Engels
Journal:  Am J Transplant       Date:  2017-11-01       Impact factor: 9.369

10.  Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation.

Authors:  I S D Roberts; D Besarani; P Mason; G Turner; P J Friend; R Newton
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.